Literature DB >> 15009071

Development and functional analysis of eosinophils from murine embryonic stem cells.

Emi Hamaguchi-Tsuru1, Atsuya Nobumoto, Noriyuki Hirose, Sayo Kataoka, Kiyomi Fujikawa-Adachi, Masato Furuya, Akira Tominaga.   

Abstract

We have established a culture system for the development of eosinophils from murine embryonic stem (ES) cells. After transferring ES cells from embryonic fibroblast cells onto macrophage colony-stimulating factor-deficient stromal cells, OP9, ES cells were cultured in the presence of interleukin (IL)-5 with either IL-3 or granulocyte-macrophage colony stimulating factor (GM-CSF) for 20 d to obtain approximately 50% eosinophils. Electron microscopy confirmed the presence of crystallized major basic protein (MBP) in the granules of some of these cells. Neither IL-5, IL-3, GM-CSF nor eotaxin alone could induce eosinophils as efficiently as the conditions described above. Eotaxin induced eosinophil development in combination with either IL-3 or IL-5. Levels of GATA-1, Friend of GATA (FOG)-1, PU.1, CCAAT/enhancer binding protein (C/EBP)alpha, C/EBPbeta, IL-3 receptor alpha (IL-3Ralpha), GM-CSF receptor alpha (GM-CSFRalpha), and MBP mRNAs were increased in ES cells 10 d after transfer onto OP9 cells. In contrast, C/EBPepsilon, IL-5Ralpha, and eosinophil peroxidase mRNAs were induced in response to IL-3 and IL-5 after transfer onto OP9 cells. Eosinophils that developed in this system expressed Gr-1, F4/80, B220, CCR3, IL-3Ralpha, IL-5Ralpha, and DX5. Finally, eosinophils developed from ES cells produced reactive oxygen species in response to Leishmania as do peripheral blood eosinophils.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009071     DOI: 10.1111/j.1365-2141.2004.04850.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

Review 1.  Models of haematopoiesis: seeing the wood for the trees.

Authors:  Rhodri Ceredig; Antonius G Rolink; Geoffrey Brown
Journal:  Nat Rev Immunol       Date:  2009-04       Impact factor: 53.106

2.  Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.

Authors:  Jeffrey M Milush; Brian R Long; Jennifer E Snyder-Cappione; Amedeo J Cappione; Vanessa A York; Lishomwa C Ndhlovu; Lewis L Lanier; Jakob Michaëlsson; Douglas F Nixon
Journal:  Blood       Date:  2009-10-05       Impact factor: 22.113

Review 3.  Advances in cellular technology in the hematology field: What have we learned so far?

Authors:  Gustavo Torres de Souza; Claudinéia Pereira Maranduba; Camila Maurmann de Souza; Danielle Luciana Aurora Soares do Amaral; Francisco Carlos da Guia; Rafaella de Souza Salomão Zanette; João Vitor Paes Rettore; Natana Chaves Rabelo; Lucas Mendes Nascimento; Ícaro França Navarro Pinto; Júlia Boechat Farani; Abrahão Elias Hallack Neto; Fernando de Sá Silva; Carlos Magno da Costa Maranduba; Angelo Atalla
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

4.  Murine lung eosinophil activation and chemokine production in allergic airway inflammation.

Authors:  C Edward Rose; Joanne A Lannigan; Paul Kim; James J Lee; Shu Man Fu; Sun-sang J Sung
Journal:  Cell Mol Immunol       Date:  2010-07-12       Impact factor: 11.530

Review 5.  Designer blood: creating hematopoietic lineages from embryonic stem cells.

Authors:  Abby L Olsen; David L Stachura; Mitchell J Weiss
Journal:  Blood       Date:  2005-10-27       Impact factor: 22.113

6.  Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells.

Authors:  Gang-Ming Zou; Jian-Jun Chen; Mervin C Yoder; Wei Wu; Janet D Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-01       Impact factor: 11.205

Review 7.  De novo formed satellite DNA-based mammalian artificial chromosomes and their possible applications.

Authors:  Robert L Katona
Journal:  Chromosome Res       Date:  2015-02       Impact factor: 5.239

8.  Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46.

Authors:  Thierry Walzer; Mathieu Bléry; Julie Chaix; Nicolas Fuseri; Lionel Chasson; Scott H Robbins; Sébastien Jaeger; Pascale André; Laurent Gauthier; Laurent Daniel; Karine Chemin; Yannis Morel; Marc Dalod; Jean Imbert; Michel Pierres; Alessandro Moretta; François Romagné; Eric Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

9.  Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors.

Authors:  Kyung-Dal Choi; Maxim A Vodyanik; Igor I Slukvin
Journal:  J Clin Invest       Date:  2009-08-10       Impact factor: 14.808

Review 10.  Autologous blood cell therapies from pluripotent stem cells.

Authors:  Claudia Lengerke; George Q Daley
Journal:  Blood Rev       Date:  2009-11-11       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.